Research ExplorerPublicationsPatient-relevant Treatment Goals in Psoriasis

Patient-relevant Treatment Goals in Psoriasis

Standard

Patient-relevant Treatment Goals in Psoriasis. / Blome, Christine; Gosau, Ramona ; Radtke, Marc A; Reich, Kristian; Rustenbach, Stephan J; Spehr, Christina; Thaçi, Diamant; Augustin, Matthias.

In: ARCH DERMATOL RES, Vol. 308, No. 2, 03.2016, p. 69-78.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Blome, C, Gosau, R, Radtke, MA, Reich, K, Rustenbach, SJ, Spehr, C, Thaçi, D & Augustin, M 2016, 'Patient-relevant Treatment Goals in Psoriasis', ARCH DERMATOL RES, vol. 308, no. 2, pp. 69-78. https://doi.org/10.1007/s00403-015-1613-8

APA

Blome, C., Gosau, R., Radtke, M. A., Reich, K., Rustenbach, S. J., Spehr, C., Thaçi, D., & Augustin, M. (2016). Patient-relevant Treatment Goals in Psoriasis. ARCH DERMATOL RES, 308(2), 69-78. https://doi.org/10.1007/s00403-015-1613-8

Vancouver

Blome C, Gosau R, Radtke MA, Reich K, Rustenbach SJ, Spehr C et al. Patient-relevant Treatment Goals in Psoriasis. ARCH DERMATOL RES. 2016 Mar;308(2):69-78. https://doi.org/10.1007/s00403-015-1613-8

Bibtex

@article{5901052d2407404d96a5b127b193964a,
title = "Patient-relevant Treatment Goals in Psoriasis",
abstract = "Patient-oriented care requires therapeutic decisions to agree with the patients' treatment needs and goals. This study addressed the following questions: What is important to psoriasis patients starting systemic treatment? How stable are these preferences within the first year of treatment? Are treatment goals associated with age, gender, or treatment success? The importance of treatment goals was assessed for patients with moderate-to-severe psoriasis in the German Psoriasis Registry (PsoBest) at baseline (onset of a systemic treatment; n = 3066) and at a 1-year follow-up (n = 1444) using the Patient Benefit Index (PBI). Treatment success was measured with PBI global score and Psoriasis Area Severity Index (PASI). Patients with moderate-to-severe psoriasis pursued a wide range of different goals. The most general treatment goals were rated most relevant, including skin healing and quick skin improvement (94.8/94.5 % {"}quite{"} or {"}very{"} important), confidence in the therapy (93.0 %), control over the disease (92.3 %), and a clear diagnosis and therapy (89.6 %). Further important goals related to not being in fear of the disease getting worse (84.8 %), reduction in itching (83.9 %), burning (70.6 %), and pain (60.6 %) as well as attaining a normal everyday life (78.4 %) and low treatment burden (64.2-77.9 %). Goals were mostly not associated with sex and gender. Goal importance slightly increased with treatment success. In a substantial proportion of patients (30.3-54.7 %) goal importance changed within 1 year after onset of systemic treatment. We conclude that treatment goal importance should be assessed in clinical practice on a regular basis.",
keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Patient Preference, Patient-Centered Care, Psoriasis, Quality of Life, Registries, Severity of Illness Index, Treatment Outcome, Young Adult, Journal Article, Research Support, Non-U.S. Gov't",
author = "Christine Blome and Ramona Gosau and Radtke, {Marc A} and Kristian Reich and Rustenbach, {Stephan J} and Christina Spehr and Diamant Tha{\c c}i and Matthias Augustin",
year = "2016",
month = mar,
doi = "10.1007/s00403-015-1613-8",
language = "English",
volume = "308",
pages = "69--78",
journal = "ARCH DERMATOL RES",
issn = "0340-3696",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Patient-relevant Treatment Goals in Psoriasis

AU - Blome, Christine

AU - Gosau, Ramona

AU - Radtke, Marc A

AU - Reich, Kristian

AU - Rustenbach, Stephan J

AU - Spehr, Christina

AU - Thaçi, Diamant

AU - Augustin, Matthias

PY - 2016/3

Y1 - 2016/3

N2 - Patient-oriented care requires therapeutic decisions to agree with the patients' treatment needs and goals. This study addressed the following questions: What is important to psoriasis patients starting systemic treatment? How stable are these preferences within the first year of treatment? Are treatment goals associated with age, gender, or treatment success? The importance of treatment goals was assessed for patients with moderate-to-severe psoriasis in the German Psoriasis Registry (PsoBest) at baseline (onset of a systemic treatment; n = 3066) and at a 1-year follow-up (n = 1444) using the Patient Benefit Index (PBI). Treatment success was measured with PBI global score and Psoriasis Area Severity Index (PASI). Patients with moderate-to-severe psoriasis pursued a wide range of different goals. The most general treatment goals were rated most relevant, including skin healing and quick skin improvement (94.8/94.5 % "quite" or "very" important), confidence in the therapy (93.0 %), control over the disease (92.3 %), and a clear diagnosis and therapy (89.6 %). Further important goals related to not being in fear of the disease getting worse (84.8 %), reduction in itching (83.9 %), burning (70.6 %), and pain (60.6 %) as well as attaining a normal everyday life (78.4 %) and low treatment burden (64.2-77.9 %). Goals were mostly not associated with sex and gender. Goal importance slightly increased with treatment success. In a substantial proportion of patients (30.3-54.7 %) goal importance changed within 1 year after onset of systemic treatment. We conclude that treatment goal importance should be assessed in clinical practice on a regular basis.

AB - Patient-oriented care requires therapeutic decisions to agree with the patients' treatment needs and goals. This study addressed the following questions: What is important to psoriasis patients starting systemic treatment? How stable are these preferences within the first year of treatment? Are treatment goals associated with age, gender, or treatment success? The importance of treatment goals was assessed for patients with moderate-to-severe psoriasis in the German Psoriasis Registry (PsoBest) at baseline (onset of a systemic treatment; n = 3066) and at a 1-year follow-up (n = 1444) using the Patient Benefit Index (PBI). Treatment success was measured with PBI global score and Psoriasis Area Severity Index (PASI). Patients with moderate-to-severe psoriasis pursued a wide range of different goals. The most general treatment goals were rated most relevant, including skin healing and quick skin improvement (94.8/94.5 % "quite" or "very" important), confidence in the therapy (93.0 %), control over the disease (92.3 %), and a clear diagnosis and therapy (89.6 %). Further important goals related to not being in fear of the disease getting worse (84.8 %), reduction in itching (83.9 %), burning (70.6 %), and pain (60.6 %) as well as attaining a normal everyday life (78.4 %) and low treatment burden (64.2-77.9 %). Goals were mostly not associated with sex and gender. Goal importance slightly increased with treatment success. In a substantial proportion of patients (30.3-54.7 %) goal importance changed within 1 year after onset of systemic treatment. We conclude that treatment goal importance should be assessed in clinical practice on a regular basis.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Patient Preference

KW - Patient-Centered Care

KW - Psoriasis

KW - Quality of Life

KW - Registries

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Young Adult

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1007/s00403-015-1613-8

DO - 10.1007/s00403-015-1613-8

M3 - SCORING: Journal article

C2 - 26688112

VL - 308

SP - 69

EP - 78

JO - ARCH DERMATOL RES

JF - ARCH DERMATOL RES

SN - 0340-3696

IS - 2

ER -